Table 3.

Table demonstrates the results from the second round of flow cytometry examination of W0-2 and secondary antibody staining, together with CD14, CD16, CD45 antibodies, involving the percentages of lymphocyte subtypes, such as NK cells and T&B cells, and monocyte subsets, including intermediate, classic and non-classic monocytes, and percentage of Aβ⁺⁺ monocytes in the monocyte subsets, and mean fluorescent intensity of the monocyte subsets in 113 participants (64 CU, 25 MCI, and 24 AD-dementia)

Tube of W0−2 + 2nd and CD14, CD16, CD45	CU (n = 64)	MCI (n = 25)	AD-Dementia (n = 24)
1) Lymphocyte subtypes:
% of NK cells (CD45+CD14−CD16+)	17.8 ± 8	17.4 ± 5.2	12.7 ± 7.5
% of T&B cells (CD45+CD14−CD16−)	82.2 ± 8	82.6 ± 5.2	87.3 ± 7.5
2) Monocyte subsets:
% of Intermediate Monocytes (CD45+CD14+CD16+)	7 ± 4.5	5.9 ± 2.4	4.9 ± 2.7
% of Aβ++ Intermediate Monocytes	3.5 ± 4.7	2.1 ± 2.7	2.9 ± 3.9
MFI of Intermediate Monocytes	434.3 ± 423.7	320.5 ± 278.7	416.4 ± 352.3
% of Classic Monocytes (CD45+CD14+CD16−)	47 ± 16.4	48.3 ± 11.8	58.3 ± 12.3
% of Aβ++ Classic Monocytes	0.23 ± 0.32	0.18 ± 0.3	0.15 ± 0.22
MFI of Classic Monocytes	163.7 ± 100	143.2 ± 89.5	138.2 ± 59.4
% of Non-classic Monocytes (CD45+CD14−CD16+)	14.2 ± 6.8	12.2 ± 6.2	12.9 ± 6.9
% of Aβ++ Non-classic Monocytes	0.35 ± 0.93	0.16 ± 0.45	0.12 ± 0.28
MFI of Non-classic Monocytes	104.8 ± 101.2	90.2 ± 66.8	101.5 ± 62.2

Data is presented as Mean ± SD.